EP4198034 - BENZIMIDAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 19.05.2023 Database last updated on 14.06.2024 | |
Former | The international publication has been made Status updated on 21.02.2022 | Most recent event Tooltip | 15.12.2023 | Supplementary search report | published on 17.01.2024 [2024/03] | 15.12.2023 | Change - classification | published on 17.01.2024 [2024/03] | 15.12.2023 | Change - classification | published on 17.01.2024 [2024/03] | Applicant(s) | For all designated states Tuojie Biotech (Shanghai) Co., Ltd. Room 103, No. 14 Building No. 3728 Jinke Road Free Trade Pilot Zone Pudong New District Shanghai 201203 / CN | [2023/25] | Inventor(s) | 01 /
LI, Wenming Shanghai 201203 / CN | 02 /
LIU, Ning Shanghai 201203 / CN | 03 /
LIU, Biao Shanghai 201203 / CN | 04 /
LIU, Haomiao Shanghai 201203 / CN | 05 /
YU, Jian Shanghai 201203 / CN | 06 /
ZOU, Hao Shanghai 201203 / CN | 07 /
ZHU, Wei Shanghai 201203 / CN | 08 /
LI, Zhengtao Shanghai 201203 / CN | 09 /
ZHANG, Zhen Shanghai 201203 / CN | 10 /
LI, Yunfei Shanghai 201203 / CN | [2023/25] | Representative(s) | Dragotti & Associati S.R.L., et al Via Nino Bixio, 7 20129 Milano / IT | [N/P] |
Former [2023/25] | Viganò, Elena, et al Dragotti & Associati S.r.l. Via Nino Bixio, 7 20129 Milano / IT | Application number, filing date | 21855617.3 | 13.08.2021 | [2023/25] | WO2021CN112386 | Priority number, date | CN202010811267 | 13.08.2020 Original published format: CN202010811267 | CN202110609305 | 01.06.2021 Original published format: CN202110609305 | [2023/25] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022033567 | Date: | 17.02.2022 | Language: | ZH | [2022/07] | Type: | A1 Application with search report | No.: | EP4198034 | Date: | 21.06.2023 | Language: | EN | [2023/25] | Search report(s) | International search report - published on: | CN | 17.02.2022 | (Supplementary) European search report - dispatched on: | EP | 14.12.2023 | Classification | IPC: | C07D413/06, A61K31/5377, A61P13/00, A61P25/04, A61P11/14 | [2023/25] | CPC: |
C07D413/14 (EP,KR,US);
A61K31/5377 (EP,KR);
A61K31/538 (KR);
A61K31/5415 (KR);
A61P11/14 (EP,KR);
A61P13/00 (EP);
A61P13/02 (KR);
A61P25/04 (EP,KR);
C07D413/06 (EP,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/25] | Title | German: | BENZIMIDAZOLDERIVATE, HERSTELLUNGSVERFAHREN DAFÜR UND MEDIZINISCHE VERWENDUNG DAVON | [2023/25] | English: | BENZIMIDAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | [2023/25] | French: | DÉRIVÉS DE BENZIMIDAZOLE, LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION MÉDICALE | [2023/25] | Entry into regional phase | 22.02.2023 | Translation filed | 22.02.2023 | National basic fee paid | 22.02.2023 | Search fee paid | 22.02.2023 | Designation fee(s) paid | 22.02.2023 | Examination fee paid | Examination procedure | 22.02.2023 | Amendment by applicant (claims and/or description) | 22.02.2023 | Examination requested [2023/25] | Fees paid | Renewal fee | 18.08.2023 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [YA]WO2011062550 (ASTRAZENECA AB [SE], et al) [Y] 1,2,5,6,12-15 * Formula (I)-(III) Reason for proviso within the defibnition of R7; pages 2-6; claims 1-19; table 1 * [A] 3,4,7-11; | [X]CN102741245 (ASTRAZENECA AB); | [YA]WO2012158117 (ASTRAZENECA AB [SE], et al) [Y] 1,2,5,6,12-15 * Formula (I) Examples Reason for proviso within the defibnition of R7;; tables 1,2 * [A] 3,4,7-11; | [I]WO2014117274 (NEOMED INST [CA]) [I] 1-15 * Formula (I); Examples Imidazopyridines instead of the present benzimidazole; page 2; table 2 *; | [I]WO2020135771 (WUHAN LL SCIENCE AND TECH DEVELOPMENT CO LTD [CN], et al)[I] 1-15; | [E]EP3889154 (WUHAN LL SCIENCE AND TECH DEVELOPMENT CO LTD [CN]) [E] 1-15 * Imidazopyridines instead of the present benzimidazole; pages 242, 246 - page 250; examples 2,101,171 * |